| Financial Year |
March 31 2023 |
| Monetary Funds |
2,347,168,274.80 |
| Held-for-trading Financial Assets |
733,125.22 |
| Notes Receivable |
200,303,746.67 |
| Accounts Receivable |
3,243,682,003.99 |
| Advances to Suppliers |
724,192,425.40 |
| Other Receivables |
99,987,415.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,779,202,982.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
324,475,780.22 |
| Total Current Assets |
12,886,614,746.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
257,791,446.63 |
| Investment Properties |
29,962,527.85 |
| Fixed Assetes |
29,374,825,238.33 |
| Under-construction Projects |
3,677,752,677.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,755,237,978.82 |
| R&D expenses |
-- |
| Goodwill |
39,413,645.38 |
| Long-Term Deferred and Prepaid Expenses |
59,550,421.34 |
| Deferred Income Tax Assets |
315,582,403.42 |
| Other Non-Current Assets |
533,977,144.27 |
| Sub-Total of Non-Current Assets |
36,207,700,338.72 |
| Total Assets |
49,094,315,085.24 |
| Short-Term Loans |
9,853,484,250.47 |
| Trading Financial liabilities |
-- |
| Notes Payable |
730,521,000.00 |
| Accounts Payable |
4,107,518,097.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
96,674,116.69 |
| Taxes Payable |
268,554,819.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
896,300,192.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,809,173,898.05 |
| Other Current Liabilities |
79,173,085.92 |
| Sub-Total of Current Liabilities |
18,495,187,371.41 |
| Long-term Loans |
6,316,352,156.69 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
289,878,889.52 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,524,721.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,967,825,146.04 |
| Total Liabilities |
25,463,012,517.45 |
| Paid-In Capital(Or Share Stock) |
2,794,684,119.00 |
| Capital Surplus |
3,597,950,653.77 |
| Surplus Reserve |
1,379,923,758.23 |
| LESS:Treasury Stock |
303,698,340.00 |
| Undistributed Profits |
15,781,944,692.28 |
| Minority Stockholder's Interest |
92,545,448.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
23,538,757,119.23 |
| Owner's Equity（Stockholder's Equity） |
23,631,302,567.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
49,094,315,085.24 |
